CytoGenix, Inc. and USAMRIID to Collaborate in Developing Biodefense synDNA(TM) Vaccines

March 27, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

HOUSTON--(BUSINESS WIRE)--CytoGenix, Inc. (CYGX.OB) announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

Twitter
LinkedIn
Facebook
Email
Print

Alliances